Open Access Open Access  Restricted Access Subscription or Fee Access

3′,4′-Methylenedioxy Moiety Containing Murrayanine Based Chalcone as Emerging Anti-inflammatory Agent



Natural products are the emerging compounds for treating a wide variety of ailments. In a recent trend, rational semi-synthesis remained an impressive approach for developing inhibitors with pronounced activity. 3′,4′-methylenedioxy have been found to be present in a variety of compounds expressing anti-mycobacterial, anti-inflammatory, anti-cancer, analgesic, anti-pyretic, etc. The present study focuses on the rational development of (E)-3-(benzo[d][1,3]dioxol-5-yl)-1-(1-methoxy-9H-carbazol-3-yl)prop-2-en-1-one from murrayanine and 3′,4′-(methylenedioxy)acetophenone and investigating the anti-inflammatory activity of the fabricated hybrid. The influence of the 3′,4′-methylenedioxy group present in the ring-B of the murrayanine-chalcone scaffold was explored. The optimization of the essential structure and their emphasis on pronounce activity was determined. The present work revealed the fabrication of 3′,4′-methylenedioxy moiety containing murrayanine based chalcone through a semi-synthetic approach. The compound through 3′,4′-methylenedioxy portion exhibited anti-inflammatory potential after 3 hrs by inhibiting cyclooxygenase-2 (COX-2) and lipoxygenase (LOX), the major intermediates and promoter of inflammatory responses. Lipophilicity may be considered as a key factor in exhibiting the biological activity via swiftly crossing the biological membrane. The research has opened new doors for developing the natural product based inhibitors which will have better edema reducing potentials with low toxicity. The study will inspire the chemists in developing therapeutically active natural products based 3′,4′-methylenedioxy compounds.


Murraya koenigii; Murrayanine; Chalcone; 3′,4′-methylenedioxy; Inflammatory; Synthesis

Full Text:



Chhajed SS, Upasani C, Wadher SJ, Mahapatra DK. Medicinal Chemistry. Nashik: Career Publications Private Limited, 2017.

Mahapatra DK, Bharti SK, Eds. Handbook of Research on Medicinal Chemistry. New Jersey: Apple Academic Press, 2017.

Mahapatra DK, Bharti SK. Drug Design. New Delhi: Tara Publications Private Limited, 2016.

Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: Structural and molecular target perspectives. Eur J Med Chem 2015;98:69-114.

Mahapatra DK, Shivhare RS, Asati V. Locomotor inhibitory activity of some Murrayanine-Chalcone based 2,3-dihydrobenzo[b][1,4]thiazepine derivatives: Exploring Anxiolytic potentials. Chronicle Pharm Sci 2018;2(1):462-468.

Shivhare RS, Mahapatra DK, Nair RR, Deshmukh SN. Schiff’s base derivatives of murrayanine demonstrated enhanced anti-oxidant activity than its parent moiety. Indian J Pharm Edu Res 2016;50(3):9-15.

Mahapatra DK, Chhajed SS, Shivhare RS. Development of Murrayanine-Chalcone hybrids: An effort to combine two privilege scaffolds for enhancing hypoglycemic activity. Int J Pharm Chem Anal 2017;4(2):30-34.

Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors. In J Pharm Sci Drug Res 2017;9(3):139-144.

Mahapatra DK, Shivhare RS, Kumar P. Murrayanine-chalcone transformed into novel pyrimidine compounds demonstrated promising anti-inflammatory activity. Asian J Pharm Res 2018;8(1):6-10.

Mahapatra DK, Shivhare RS, Joseph TM. Design and characterization of Murrayanine linked Isoxazole derivatives: Novel class of bacteriocidal agents. Int J Res Drugs Pharm Sci 2017;1(1):11-15.

Mahapatra DK, Shivhare RS, Bharti SK. Novel Murrayanine based Pyrazole analogs as emerging anti-fungal candidates: Design, synthesis, characterization, and in vitro evaluation. Res Pharm 2017; 1(1): 1-5.

Mahapatra DK, Shivhare RS. Synthesizing an anti-oxidant principle 2-(((1-methoxy-9H-carbazol-3-yl)methylene)amino)isoindoline-1,3-dione from N-aminophthalimide and murrayanine. Inventi Med Chem 2017;2017(4):1-3.

Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem 2018;2(2):47-51.

Mahapatra DK, Shivhare RS, Haldar AGM. Novel Schiff’s base containing Murrayanine–1,3,4-Thiadiazole Hybrids as potential anti-inflammatory agents. Asian J Chem Pharm Sci 2017;2(2):10-15.

Mahapatra DK, Shivhare RS, Gupta SD. Anxiolytic activity of some 2,3-dihydrobenzo[b][1,4]oxazepine derivatives synthesized from Murrayanine-Chalcone. Asian J Res Pharm Sci 2018;8(1):25-29.

Mahapatra DK, Shivhare RS, Ugale VG. Anti-inflammatory potentials of some novel Murrayanine containing 1,3,4-Oxadiazole derivatives. Asian J Pharm Technol 2018;8(1):47-51.

Bezerra-Netto HJ, Lacerda DI, Miranda AL, Alves HM, Barreiro EJ, Fraga CA. Design and synthesis of 3, 4-methylenedioxy-6-nitrophenoxyacetylhydrazone derivatives obtained from natural safrole: new lead-agents with analgesic and antipyretic properties. Bioorg Med Chem 2006;14(23):7924-35.

Giridharan P, Somasundaram ST, Perumal K, Vishwakarma RA, Karthikeyan NP, Velmurugan R, Balakrishnan A. Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. British J Cancer 2002;87(1):98.

Ventura TL, Calixto SD, Abrahim-Vieira BD, Souza AM, Mello MV, Rodrigues CR, Miranda LS, de Souza RO, Leal IC, Lasunskaia EB, Muzitano MF. Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach. Molecules 2015;20(5):8072-93.

Siddiqa A, Rehman AU, Abbasi MA, Rasool S, Khan KM, Ahmad I, Afzal S. Synthesis and antibacterial evaluation of 2-(1, 3-Benzodioxol-5-ylcarbonyl) arylsulfonohydrazide derivatives. Trop J Pharm Res 2014;13(10):1689-96.

Kanhed AA, Mehere AP, Pandey KR, Mahapatra DK. 4-(2-chloroacetamido) Benzoic Acid Derivatives as Local Anesthetic Agents: Design, Synthesis, and Characterization. UK J Pharm Biosci 2016; 4(6): 35-44.

Amdare MD, Jogdand KR, Kathane LL, Kuhite NG, Padole CD, Mahapatra DK. Synthesis of a potential anti-inflammatory pyrazole derivative from hippuric acid as the starting material. J Pharm Chem Biol Sci 2017;5(3):216-220.



  • There are currently no refbacks.